{"id":"https://openalex.org/W2002405282","doi":"https://doi.org/10.2143/ac.64.1.2034354","title":"Cost-effectiveness of statins in the primary prevention of cardiovascular disease: a systematic review and economic analysis for Belgium","display_name":"Cost-effectiveness of statins in the primary prevention of cardiovascular disease: a systematic review and economic analysis for Belgium","alternate_titles":[],"publication_year":2009,"publication_date":"2009-02-28","ids":{"openalex":"https://openalex.org/W2002405282","doi":"https://doi.org/10.2143/ac.64.1.2034354","mag":"2002405282","pmid":"https://pubmed.ncbi.nlm.nih.gov/19317290"},"language":"en","primary_location":{"id":"doi:10.2143/ac.64.1.2034354","doi":"https://doi.org/10.2143/ac.64.1.2034354","is_oa":false,"landing_page_url":"https://doi.org/10.2143/ac.64.1.2034354","pdf_url":null,"source":{"id":"https://openalex.org/S18670189","display_name":"Acta Cardiologica","issn_l":"0001-5385","issn":["0001-5385","1784-973X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Cardiologica","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2002405282"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034807071","display_name":"Mattias Neyt","orcid":"https://orcid.org/0000-0002-9593-3887","observed_orcids":["https://orcid.org/0000-0002-9593-3887"]},"institutions":[{"id":"https://openalex.org/I4210129284","display_name":"Belgian Health Care Knowledge Centre (KCE)","ror":"https://ror.org/02depad46","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210129284"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Neyt","raw_affiliation_strings":["Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium. Mattias.Neyt@kce.fgov.be"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium. Mattias.Neyt@kce.fgov.be","institution_ids":["https://openalex.org/I4210129284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061099846","display_name":"Chris E. D. H. De Laet","orcid":"https://orcid.org/0000-0002-1951-2079","observed_orcids":["https://orcid.org/0000-0002-1951-2079"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. De Laet","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008286586","display_name":"Hans Van Brabandt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H. Van Brabandt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056326170","display_name":"Oscar H. Franco","orcid":"https://orcid.org/0000-0002-4606-4929","observed_orcids":["https://orcid.org/0000-0002-4606-4929"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"O. Franco","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5006245725","display_name":"Dirk Ramaekers","orcid":"https://orcid.org/0000-0002-2660-0181","observed_orcids":["https://orcid.org/0000-0002-2660-0181"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. Ramaekers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.9616,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.86687247,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"64","issue":"1","first_page":"1","last_page":"10"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9154999852180481,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9154999852180481,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.07840000092983246,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T14212","display_name":"Health Promotion and Cardiovascular Prevention","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.996999979019165},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9309999942779541},{"id":"https://openalex.org/keywords/primary-prevention","display_name":"primary prevention","score":0.9120000004768372},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.9990000128746033},{"id":"https://openalex.org/keywords/low-dose-aspirin","display_name":"low-dose aspirin","score":0.9850000143051147},{"id":"https://openalex.org/keywords/smoking-cessation","display_name":"smoking cessation","score":0.9990000128746033},{"id":"https://openalex.org/keywords/middle-aged-adults","display_name":"middle-aged adults","score":0.824999988079071},{"id":"https://openalex.org/keywords/drug-spending","display_name":"drug spending","score":0.4180000126361847},{"id":"https://openalex.org/keywords/life-years-gained","display_name":"life-years gained","score":0.5830000042915344},{"id":"https://openalex.org/keywords/economic-evaluation","display_name":"economic evaluation","score":0.5889999866485596}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9342273473739624},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.7844263315200806},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.6627777218818665},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.5939087867736816},{"id":"https://openalex.org/C2777843972","wikidata":"https://www.wikidata.org/wiki/Q2462253","display_name":"Smoking cessation","level":2,"score":0.4961749017238617},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4520131051540375},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.45172399282455444},{"id":"https://openalex.org/C127454912","wikidata":"https://www.wikidata.org/wiki/Q942582","display_name":"Cost\u2013benefit analysis","level":2,"score":0.42108726501464844},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.3723670244216919},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36217793822288513},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.34072017669677734},{"id":"https://openalex.org/C149923435","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demography","level":1,"score":0.33186453580856323},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.20152196288108826},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001530","descriptor_name":"Belgium","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006291","descriptor_name":"Health Policy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011322","descriptor_name":"Primary Prevention","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D011322","descriptor_name":"Primary Prevention","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D016540","descriptor_name":"Smoking Cessation","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018803","descriptor_name":"Models, Economic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.2143/ac.64.1.2034354","doi":"https://doi.org/10.2143/ac.64.1.2034354","is_oa":false,"landing_page_url":"https://doi.org/10.2143/ac.64.1.2034354","pdf_url":null,"source":{"id":"https://openalex.org/S18670189","display_name":"Acta Cardiologica","issn_l":"0001-5385","issn":["0001-5385","1784-973X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Cardiologica","raw_type":"journal-article"},{"id":"pmid:19317290","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19317290","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta cardiologica","raw_type":"Journal Article"},{"id":"pmh:oai:repository.kce.fgov.be:2334","doi":null,"is_oa":false,"landing_page_url":"https://kce.docressources.info/index.php?lvl=notice_display&amp;id=2334","pdf_url":null,"source":{"id":"https://openalex.org/S4306401035","display_name":"KCE repository (Belgian Health Care Knowledge Centre)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210129284","host_organization_name":"Belgian Health Care Knowledge Centre (KCE)","host_organization_lineage":["https://openalex.org/I4210129284"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2134312762","https://openalex.org/W2071527741","https://openalex.org/W2343741006","https://openalex.org/W2044064409","https://openalex.org/W2020709168","https://openalex.org/W118826183","https://openalex.org/W7155410476","https://openalex.org/W178477505","https://openalex.org/W2270043737"],"abstract_inverted_index":{"OBJECTIVES:":[0],"8%":[1],"of":[2,15,23,29,132,199,205,226],"total":[3],"drug":[4],"spending":[5],"by":[6],"the":[7,21,26,69,105,113,117,184,197,202,217],"Belgian":[8,35,70,118],"government":[9],"goes":[10],"to":[11,19,147,172,176,191],"statins.":[12],"The":[13,150],"aim":[14],"this":[16],"study":[17],"is":[18,207,220,232,247],"determine":[20],"cost-effectiveness":[22,198],"statins":[24,83,200],"for":[25,201],"primary":[27,203,242],"prevention":[28,204,228],"cardiovascular":[30],"disease":[31],"(CVD)":[32],"in":[33,44,104,128,139,153,210,241],"middle-aged":[34],"populations.":[36],"METHODS":[37],"AND":[38],"RESULTS:":[39],"Economic":[40],"evaluations":[41,77],"were":[42,50,78,102],"identified":[43],"a":[45,58,140,154,238,248],"systematic":[46],"literature":[47],"search":[48],"and":[49,87,235],"critically":[51],"appraised.":[52],"Furthermore,":[53],"because":[54],"prices":[55],"decreased":[56],"drastically,":[57],"previously":[59],"published":[60],"model":[61],"was":[62,160,165,183],"adapted":[63],"applying":[64],"recent":[65],"cost":[66,124,131,152],"data":[67],"from":[68,169],"national":[71],"health":[72],"insurance.":[73],"Eleven":[74],"full":[75],"economic":[76,224],"identified.":[79],"Nine":[80],"studies":[81],"compared":[82,146,175,190],"with":[84,212,229],"no":[85,192],"treatment":[86,101],"presented":[88],"heterogeneous":[89],"results.":[90],"If":[91],"alternative":[92],"interventions,":[93],"such":[94],"as":[95],"smoking":[96,177],"cessation":[97,178,181],"or":[98],"low-dose":[99,148,213,230],"aspirin":[100,164,231],"included":[103],"analysis,":[106],"statin":[107,115,219],"therapy":[108,182],"became":[109],"less":[110],"cost-effective.":[111],"Prescribing":[112],"cheapest":[114,218],"on":[116],"market":[119],"(<":[120],"Euro":[121,133,161,170,173],"90":[122],"medication":[123],"per":[125,135],"year)":[126],"resulted":[127],"an":[129,223],"incremental":[130,151],"29,173":[134],"life-year":[136],"gained":[137],"(LYG)":[138],"male":[141,155],"high-risk":[142],"group":[143,157],"aged":[144,158],"60":[145],"aspirin.":[149],"moderate-risk":[156],"50":[159],"87,022/LYG.":[162],"Low-dose":[163],"more":[166,233],"cost-effective":[167,186,234],"ranging":[168],"3,854/LYG":[171],"29,509/LYG":[174],"therapy.":[179],"Smoking":[180,244],"most":[185],"intervention,":[187],"providing":[188],"savings":[189],"treatment.":[193],"CONCLUSIONS:":[194],"In":[195],"Belgium,":[196],"CVD":[206],"rather":[208],"elevated":[209],"comparison":[211],"aspirin,":[214],"even":[215],"if":[216],"prescribed.":[221],"From":[222],"point":[225],"view,":[227],"may":[236],"present":[237],"first":[239],"choice":[240],"prevention.":[243],"cessation,":[245],"which":[246],"dominant":[249],"strategy,":[250],"should":[251],"be":[252],"encouraged":[253],"at":[254],"all":[255],"times.":[256]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2002405282","counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
